Review




Structured Review

CoreValve Inc avr medical device
Table 5
Avr Medical Device, supplied by CoreValve Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/avr+medical+device/avr+medical+device/pmc04599371-3-20-23
Average 90 stars, based on 1 article reviews
avr medical device - by Bioz Stars, 2026-09
90/100 stars

Images

1) Product Images from "Health Status after Transcatheter or Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis at Increased Surgical Risk. Results from the CoreValve US Pivotal Trial"

Article Title: Health Status after Transcatheter or Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis at Increased Surgical Risk. Results from the CoreValve US Pivotal Trial

Journal: JACC. Cardiovascular interventions

doi: 10.1016/j.jcin.2015.04.018

Table 5
Figure Legend Snippet: Table 5

Techniques Used:

Related Articles

Functional Assay:

Article Title: Health Status after Transcatheter or Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis at Increased Surgical Risk. Results from the CoreValve US Pivotal Trial
Article Snippet: Methods Between 2011 and 2012, 795 patients with severe aortic stenosis at increased surgical risk were randomized to TAVR or AVR in the CoreValve US Pivotal Trial.



Similar Products

90
CoreValve Inc avr medical device
Table 5
Avr Medical Device, supplied by CoreValve Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/avr+medical+device/avr+medical+device/pmc04599371-3-20-23
Average 90 stars, based on 1 article reviews
avr medical device - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


Table 5

Journal: JACC. Cardiovascular interventions

Article Title: Health Status after Transcatheter or Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis at Increased Surgical Risk. Results from the CoreValve US Pivotal Trial

doi: 10.1016/j.jcin.2015.04.018

Figure Lengend Snippet: Table 5

Article Snippet: Methods Between 2011 and 2012, 795 patients with severe aortic stenosis at increased surgical risk were randomized to TAVR or AVR in the CoreValve US Pivotal Trial.

Techniques: